FEMY

FEMASYS INC
—

Company Information

Company Name
FEMASYS INC
CIK
CIK0001339005
Category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Ticker: Exchange
FEMY: Nasdaq
Fiscal Year End
December 31
Owner Organization
08 Industrial Applications and Services
SIC
3841
SIC Description
Surgical & Medical Instruments & Apparatus
Ticker
FEMY

SEC filing data through

Insider Sentiment

Last purchase
2026-08-07
Last sale
—
Shares purchased (TTM)
41,875
Shares sold (TTM)
0
Buy ratio (TTM)100.0%

Institutional Sentiment

As of
2026-06-30
Institutional shares owned
2,069,873
Shares outstanding
3,357,117
Ownership
61.66%

Earnings Market Reaction

Filing date
2026-08-14
Price on filing date
—
1-month reaction
30.13%
3-month reaction
…
Drift continued9/11 (82%)
Faded / reversed2/11 (18%)

Balance Sheet

Values in millions ($)
Line item2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-30Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets
Cash And Cash Equivalents At Carrying Value159534381418229
Accounts Receivable Net Current001100000000
Inventory Net666654321111
Other Assets Current111111111111
Assets Current812161210981116202310
Property Plant And Equipment Net
Leasehold Improvements Gross111111111111
Property Plant And Equipment Other000000000000
Furniture And Fixtures Gross000000000000
Machinery And Equipment Gross333333333333
Construction In Progress Gross111111111100
Property Plant And Equipment Gross666655555555
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment-4-4-4-4-4-4-4-4-4-4-4-4
Property Plant And Equipment Net222222211111
Assets Noncurrent
Operating Lease Right Of Use Asset1111222---2-
Finite Lived Intangible Assets Net000000000000
Other Assets Noncurrent111111111111
Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment222223333333
Assets121621161413121620242815
Liabilities And Stockholders Equity
Accounts Payable Current222232111111
Accrued Liabilities Current111111111111
Notes Payable Current---0------00
Convertible Notes Payable Current--0-665---0-
Operating Lease Liability Current0000111---0-
Liabilities Current434111110932232
Liabilities Noncurrent
Convertible Long Term Notes Payable--3---05544-
Derivative Liabilities Noncurrent015---0-----
Operating Lease Liability Noncurrent1111112---2-
Liabilities Noncurrent4611111277662
Liabilities891512121110109994
Stockholders Equity
Common Stock Value000000000000
Treasury Stock Common Value-0-0-0-0-0-0-0-0-0-0-0-0
Warrants And Rights Outstanding655722233332
Additional Paid In Capital148147146140137133128125125125124113
Retained Earnings Accumulated Deficit-149-145-146-142-138-133-127-122-117-112-108-104
Stockholders Equity4765222611161810
Liabilities And Stockholders Equity121621161413121620242815
Common Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.000.00
Common Stock Shares Authorized200200200200200200200200200200200200
Common Stock Shares Issued333221111111
Shares Outstanding333221111111
Treasury Stock Common Shares000000000000

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

FEMASYS INC (FEMY) — SEC Financial Statements & Analysis

FEMASYS INC (FEMY) is a surgical & medical instruments & apparatus company, incorporated in DE. FEMASYS INC trades on Nasdaq as: FEMY. FEMASYS INC (FEMY)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, FEMASYS INC carries a market cap of $14.03M, a P/E ratio of -1.14x, a P/B ratio of 3.48x, a P/S ratio of 6.10x, an enterprise value of $12.59M, and an EV/EBITDA multiple of -0.73x. On profitability, it posts a gross margin of 60.95%, an operating margin of -763.90%, a net margin of -534.27%, a Return on Equity (ROE) of -443.65%, a Return on Assets (ROA) of -94.25%, and a Return on Invested Capital (ROIC) of -498.94%. Per share, it reports EPS of $-3.66, diluted EPS of $-3.66, free cash flow per share of $-5.38, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 21.86% year-over-year, net income growth of -41.54% year-over-year, and EPS growth of -74.85% year-over-year. On the balance sheet, it maintains a current ratio of 2.14x, a quick ratio of 0.55x, working capital of $4.45M, a debt-to-equity ratio of 2.05x, a debt ratio of 0.67, an interest coverage ratio of -13.48x, free cash flow of $-18.07M (TTM), and net debt of $-1.44M. Figures sourced from SEC EDGAR.

Market Cap
$14.03M
P/E TTM
-1.14x
EPS TTM
$-3.66
P/B TTM
3.48x
ROE TTM
-443.65%
ROA TTM
-94.25%
Debt To Equity
2.05x
Free Cash Flow TTM
$-18.07M
Net Revenue TTM Growth 1Y
21.86%

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is FEMASYS INC in?

FEMASYS INC (FEMY) operates in the Surgical & Medical Instruments & Apparatus industry.

What exchange does FEMY trade on?

FEMASYS INC (FEMY) trades on the Nasdaq.

Where is FEMASYS INC incorporated?

FEMASYS INC is incorporated in DE.

When was FEMASYS INC (FEMY)'s most recent SEC filing?

FEMASYS INC (FEMY)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.

What is FEMY's market cap?

FEMASYS INC (FEMY) has a market capitalization of $14.03M as of 2026-06-30.

What is FEMY's EPS (earnings per share)?

FEMASYS INC (FEMY)'s trailing twelve month EPS is $-3.66 as of 2026-06-30.

What is FEMY's ROE (return on equity)?

FEMASYS INC (FEMY)'s trailing twelve month Return on Equity (ROE) is -443.65% as of 2026-06-30.

What is FEMY's ROA (return on assets)?

FEMASYS INC (FEMY)'s trailing twelve month Return on Assets (ROA) is -94.25% as of 2026-06-30.

What is FEMY's ROIC (return on invested capital)?

FEMASYS INC (FEMY)'s trailing twelve month Return on Invested Capital (ROIC) is -498.94% as of 2026-06-30.

What is FEMY's EV/EBITDA?

FEMASYS INC (FEMY)'s trailing twelve month EV/EBITDA is -0.73x as of 2026-06-30.

Wall Street's data.
Main Street's price.